期刊文献+

PEFC化疗方案治疗20例原发性输卵管癌 被引量:1

Retrospective study of PEFC chemotherapy regimen on primary carcinoma of fallopian tube
暂未订购
导出
摘要 目的 :研究PEFC(卡铂或顺铂、依托泊苷、氟尿嘧啶和环磷酰胺 )方案治疗原发性输卵管癌的治疗作用。方法 :41例原发性输卵管癌患者按化疗方案不同分成两组 ,治疗组 :2 0例患者接受PEFC方案化疗 ,对照组 :2 1例患者接受CAP(卡铂或顺铂、多柔比星、环磷酰胺 )方案化疗。结果 :PEFC组和CAP组一、三、五年无进展生存率分别为 1 0 0 %、67.34 %、67.34 % ;76 .1 9%、51 .88%、45 .40 % (P <0 .0 5)。PEFC组有 6例复发 ,CAP组有 1 3复发(P <0 .0 5)。结论 :PEFC方案化疗延缓肿瘤的复发 。 Purpose:To investigate the therapeutic effect of PEFC chemotherapy regimen (cisplatin or carboplatin,etoposide,fluorouracil and cyclophosphamide) on primary carcinoma of fallopian tube.Methods:41 patients with primary carcinoma of fallopian tube were divided into two groups: 20 patients in PEFC group received PEFC chemotherapy; 21 patients in CAP group received CAP chemotherapy. The therapeutic effects of the two groups were compared.Results:1 , 3 , 5 year progression free survival rate of PEFC group and CAP group were: 100%, 67.34%, 67.34%; 76 19%, 51 88%, 45 40% respectively ( P <0 05). 6 patients in the PEFC group and 13 patients in the CAP group relapsed ( P <0 05). Conclusions:PEFC chemotherapy regimen can delay relapse and improve quality of survival in patients with primary carcinoma of fallopian tube. [
作者 林晓 孙红
出处 《中国癌症杂志》 CAS CSCD 2003年第3期256-258,共3页 China Oncology
关键词 PEFC 化疗方案 治疗 原发性 输卵管癌 primary carcinoma of fallopian tube chemotherapy prognosis
  • 相关文献

参考文献5

  • 1Gemignani ML, Hensley ML, Cohen R, et al. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube [ J ]. Gynecol Oncol,2001,80 ( 1 ) : 16-20.
  • 2McGuire WP. Epithelial ovarian cancer [ M ]. New York:Lippincott Raven ,2000:541-546.
  • 3Gadducci A, Landoni F, Sartori E, et al. Analysis of treatment failures and survival of patients with fallopian tube carclnoma:a cooperation task force study [ J ]. Gynecol Oncol, 2001,81 ( 2 ) :150-159.
  • 4Peter WA III, Andersen WA, Hopkins MP, et al. Prognostic features of carcinoma of the fallopian tube [ J ]. Obstet Gynecol,1988,71(5 ) :757-762.
  • 5Wagenaar HC, Pecorelli S, Vergote I,et al. Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma: an EORTC gynecological cancer group study [ J ]. Eur J Gynaecol Oncol, 2001,22 ( 3 ) :187-193.

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部